Literature DB >> 14102022

CASE OF HASHIMOTO'S DISEASE WITH MYASTHENIA GRAVIS.

J J DALY, E JACKSON.   

Abstract

Entities:  

Keywords:  AUTOIMMUNE DISEASES; MYASTHENIA GRAVIS; THYROIDITIS, LYMPHOMATOUS

Mesh:

Year:  1964        PMID: 14102022      PMCID: PMC1815178          DOI: 10.1136/bmj.1.5385.748

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  10 in total

1.  MULTIPLE ANTIBODY PRODUCTION IN MYASTHENIA GRAVIS.

Authors:  H VAN DER GELD; T E FELTKAMP; J VAN LOGHEM; H J OOSTERHUIS; A BIEMOND
Journal:  Lancet       Date:  1963-08-24       Impact factor: 79.321

2.  Lymphoepithelial structures and autoimmune disease.

Authors:  F M BURNET; I R MACKAY
Journal:  Lancet       Date:  1962-11-17       Impact factor: 79.321

3.  Lymphadenoid goitre and the syndrome of systemic lupus erythematosus.

Authors:  R G WHITE; B H BASS; E WILLIAMS
Journal:  Lancet       Date:  1961-02-18       Impact factor: 79.321

4.  Two auto-immune diseases in one patient: a case of hemolytic anemia and Hashimoto's thyroiditis.

Authors:  C WASASTJERNA
Journal:  Acta Med Scand       Date:  1959-11-18

5.  Thyroid function and myasthenia gravis.

Authors:  A G ENGEL
Journal:  Arch Neurol       Date:  1961-06

6.  Changes in serum complement activity in patients with myasthenia gravis.

Authors:  W L NASTUK; O J PLESCIA; K E OSSERMAN
Journal:  Proc Soc Exp Biol Med       Date:  1960-10

7.  Myasthenia gravis followed by systemic lupus erythematosus. A case report.

Authors:  D DENNEY; R L ROSE
Journal:  Neurology       Date:  1961-08       Impact factor: 9.910

8.  Myasthenia gravis and myxedema.

Authors:  W D FEINBERG; L O UNDERDAHL; L M EATON
Journal:  Proc Staff Meet Mayo Clin       Date:  1957-06-12

9.  Hashimoto's struma lymphomatosa; diagnostic value and significance of serum-flocculation reactions.

Authors:  R W LUXTON; R T COOKE
Journal:  Lancet       Date:  1956-07-21       Impact factor: 79.321

10.  Systemic lupus erythematosus: review of the literature and clinical analysis of 138 cases.

Authors:  A M HARVEY; L E SHULMAN; P A TUMULTY; C L CONLEY; E H SCHOENRICH
Journal:  Medicine (Baltimore)       Date:  1954-12       Impact factor: 1.889

  10 in total
  8 in total

1.  IMMUNOLOGICAL DISTURBANCES IN MYASTHENIA GRAVIS WITH A REPORT OF HASHIMOTO'S DISEASE DEVELOPING AFTER THYMECTOMY.

Authors:  J A SIMPSON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1964-12       Impact factor: 10.154

Review 2.  [The pathogenesis of myasthenia gravis as an immunological problem].

Authors:  J R Kalden
Journal:  Klin Wochenschr       Date:  1970-01-01

3.  Genetic study of sample of 70 patients with myasthenia gravis.

Authors:  A Jacob; E R Clack; A E Emery
Journal:  J Med Genet       Date:  1968-12       Impact factor: 6.318

4.  [Immune-pathological concomitant diseases and phenomena of lupus erythematosus].

Authors:  A Gamp; F Schilling
Journal:  Klin Wochenschr       Date:  1965-08-15

5.  Polyradicular neuritis and Hashimoto's thyroiditis.

Authors:  G Potz; B Neundörfer
Journal:  J Neurol       Date:  1975-10-24       Impact factor: 4.849

6.  Episodic encephalopathy associated with thyroid disorders.

Authors:  D C Thrush; H G Boddie
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-06       Impact factor: 10.154

7.  RELATION BETWEEN MYASTHENIA GRAVIS AND THYROID DISEASE.

Authors:  B M SAHAY; L M BLENDIS; R GREENE
Journal:  Br Med J       Date:  1965-03-20

Review 8.  Thymus pathology in myasthenia gravis with anti-acetylcholine receptor antibodies and concomitant Hashimoto's thyroiditis. A four-case series and literature review.

Authors:  Lidia Ionescu; Claudia Florida Costea; Radu Dănilă; Camelia Margareta Bogdănici; Dragoş Viorel Scripcariu; Roxana Maria Livădariu; Gabriela Florenţa Dumitrescu; Cristina Maria Gavrilescu; Raluca Alina Dragomir; Anca Sava; Andrei Ionuţ Cucu; Daniela Maria Tănase; Mihaela Dana Turliuc; Delia Gabriela Ciobanu Apostol
Journal:  Rom J Morphol Embryol       Date:  2021 Jan-Mar       Impact factor: 1.033

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.